You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 3, February 14, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Thrombolysis
 •Cardiovascular System
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Is Drug Monitoring a Main Cause of Excessive Anticoagulation?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Koo et al1 reported an interesting study confirming that major bleeding associated with excessive anticoagulation with warfarin is also associated with an increase in mortality compared with nonexcessive anticoagulation. They state that their study findings confirm that errors in drug monitoring are the main cause of excessive anticoagulation. Although this is a logical conclusion to reach, it is not supported by the published results. I would be interested to see if they had collected data on international normalized ratio (INR) monitoring prior to the major bleeding event to ensure that adequate monitoring had been performed.

A case-control study by Kucher et al2 showed that penultimate INRs (obtained a mean ± SD of 11.6 ± 17.8 days prior to a major bleeding event) were poor predictors of major bleeding and were similar to antepenultimate INRs (obtained 18.4 ± 20.5 days prior to a major bleeding event). This study showed that there is only a brief warning period . . . [Full Text of this Article]


AUTHOR INFORMATION
Rachel Howard, MRPharmS



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

International Normalized Ratio Increase Before Warfarin-Associated Hemorrhage: Brief and Subtle
Nils Kucher, Shannon Connolly, Joshua A. Beckman, Lay Har Cheng, Kanella V. Tsilimingras, John Fanikos, and Samuel Z. Goldhaber
Arch Intern Med. 2004;164(19):2176-2179.
ABSTRACT | FULL TEXT  

The Effect of Excessive Anticoagulation on Mortality and Morbidity in Hospitalized Patients With Anticoagulant-Related Major Hemorrhage
Sophia Koo, Nils Kucher, Paul L. Nguyen, John Fanikos, Peter W. Marks, and Samuel Z. Goldhaber
Arch Intern Med. 2004;164(14):1557-1560.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.